Freenome, Inc. Common stock (FRNM) Price Prediction & ForecastFRNMFreenome, Inc. Common stock

Alphio's FRNM stock price prediction model matches the current Freenome, Inc. Common stock tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $13.29 (+1.90%). The 1-week path is $14.01 (+7.44%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Freenome, Inc. is a good buy right now due to its recent FDA approval for a colorectal cancer screening test, which has driven a 5% increase in stock price and indicates strong future revenue potential. The current price is $12.77, significantly below the analyst price target of $21, suggesting a potential upside of 64%. Additionally, the stock has shown a recent 5-day change of +8.68%, indicating positive momentum. However, a risk to consider is the negative net income reported for Q4 2025 at -740568.00 USD, which highlights ongoing financial challenges that could affect performance in the near term.

Freenome, Inc. Common stock (FRNM) last closed at $13.04, gaining +2.52%. These facts feed the 1-day and 1-week FRNM price prediction above.